Alzheimer's disease, a neurodegenerative condition, manifests through complex pathogenic processes. It primarily involves the accumulation of beta-amyloid plaques outside neurons and tau protein tangles inside neurons. These abnormalities disrupt neuronal communication, leading to cognitive decline and memory loss. The exact cause remains elusive, but genetic factors (like mutations in APP, PSEN1, PSEN2 genes) and environmental influences (such as lifestyle and cardiovascular health) play significant roles. Inflammation and oxidative stress further exacerbate neuronal damage. As the disease progresses, brain regions responsible for memory and cognitive function, like the hippocampus and cerebral cortex, shrink. Early detection through biomarkers and imaging techniques aids in managing symptoms and potentially slowing progression, highlighting ongoing research into treatments targeting these underlying mechanisms.
Title : Make a difference
Jacqueline Tuppen, Dementia UK, United Kingdom
Title : Imaging brain clearance in Alzheimer’s disease
Jun Hua, Johns Hopkins University , United States
Title : Association between APOE allele prevalence and Alzheimer's disease risk in Southwestern Uganda
Frank Balikoowa, African Research Center for Ageing & Dementia, Uganda
Title : Healthcare professionals in Somaliland had low levels of knowledge and attitudes towards dementia care: A pilot survey
Mohamed Abdilahi Duale, Frantz Fanon University, Somalia
Title : Association between depressive symptoms and cognitive impairment severity in a real-world memory clinic cohort
Yun Ju Hsieh, Taipei City Hospital, Taiwan
Title : Neuromodulation of scalp electroacupuncture in the treatment of autism spectrum disorder
Zhenhuan Liu, Nanhai Maternity and Children Hospital Affiliated to Guangzhou University of Chinese Medicine, China